Cognition Therapeutics, Inc.
CGTX
$2.86
-$0.325-10.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.59% | -8.14% | 21.08% | -41.13% | 23.06% |
| Total Depreciation and Amortization | 35.56% | -36.62% | 1.43% | 4.48% | 15.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.97% | 9.74% | -40.40% | -21.88% | -16.03% |
| Change in Net Operating Assets | 121.15% | -77.12% | -154.01% | 1,347.06% | -135.20% |
| Cash from Operations | 43.07% | -17.84% | -22.35% | -14.24% | 17.21% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.69% | 39.49% | -5.41% | -2.21% | -1.69% |
| Issuance of Common Stock | -39.93% | -88.69% | 2,410.70% | -63.13% | -88.65% |
| Repurchase of Common Stock | 89.13% | -- | -- | 100.00% | 79.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.98% | -88.61% | 3,359.27% | 338.41% | -101.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 43.24% | -386.22% | 145.97% | -6.26% | -229.25% |